Showing 1 - 20 results of 52 for search 'Pringle, I', query time: 0.03s
Refine Results
-
1
Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects. by Pringle, I, Hyde, S, Gill, DR
Published 2009Journal article -
2
Progress and prospects: the design and production of plasmid vectors. by Gill, DR, Pringle, I, Hyde, S
Published 2009Journal article -
3
Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery by Pringle, I, Gill, D, Hyde, S
Published 2018Conference item -
4
The development of gene therapy for diseases of the lung. by Gill, DR, Davies, L, Pringle, I, Hyde, S
Published 2004Journal article -
5
-
6
Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery by Pringle, I, Davies, L, Hyde, S, Gill, D
Published 2018Conference item -
7
A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction by Munday, R, Pringle, I, Hyde, S, Gill, D
Published 2018Conference item -
8
Detection of plasmid DNA vectors following gene transfer to the murine airways. by Pringle, I, Raman, S, Sharp, W, Cheng, S, Hyde, S, Gill, DR
Published 2005Journal article -
9
743. Minicircles are similar to plasmids in providing high level, long-term expression in the lung by Gill, D, Bazzani, R, Connolly, M, Schleef, M, Hyde, S, Pringle, I
Published 2016Conference item -
10
Large-scale, high-throughput production of lentiviral vectors for multiple disease applications by Ashworth, R, Mac Reamoinn, E, Gamlen, T, Pringle, I, Gill, D, Hyde, S
Published 2018Conference item -
11
431. Lung antibody factory for passive immunisation against influenza by Tan, T, Rijal, P, Davies, L, Pringle, I, Townsend, A, Hyde, S, Gill, D
Published 2016Conference item -
12
Influence of CpG-dinucleotide motifs on the duration of gene expression from plasmid, vectors after in vivo lung delivery by Gill, DR, Lawton, A, Pringle, I, Davies, L, Yew, N, Cheng, S, Hyde, S
Published 2007Journal article -
13
-
14
-
15
3-STEP TAQMAN RT-PCR: ULTIMATE MESSENGER RNA DETECTION SENSITIVITY FOR CF GENE THERAPY CLINICAL TRIALS by McCormick, D, Sumner-Jones, S, Pringle, I, Vrettou, C, McLachlan, G, Collie, D, Gill, DR, Hyde, S
Published 2009Journal article -
16
DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY by Gill, DR, Pringle, I, Lawton, A, Connolly, M, Sumner-Jones, S, Davies, L, Meng, C, Griesenbach, U, Hyde, S
Published 2010Journal article -
17
CpG-free plasmid expression cassettes for cystic fibrosis gene therapy by Pringle, I, Hyde, S, Connolly, M, Lawton, A, Xu, B, Nunez-Alonso, G, Davies, L, Sumner-Jones, S, Gill, DR
Published 2012Journal article -
18
CpG-free plasmid expression cassettes for cystic fibrosis gene therapy. by Pringle, I, Hyde, S, Connolly, M, Lawton, A, Xu, B, Nunez-Alonso, G, Davies, L, Sumner-Jones, S, Gill, DR
Published 2012Journal article -
19
Rapid identification of novel functional promoters for gene therapy by Pringle, I, Gill, D, Connolly, M, Lawton, A, Hewitt, A, Nunez-Alonso, G, Davies, L, Hyde, S, Cheng, S, Scheule, R
Published 2012Journal article -
20